Related Experiment Videos
Towards high-throughput functional target discovery in angiogenesis research.
Judy R van Beijnum1, Wouter J Eijgelaar, Arjan W Griffioen
1Angiogenesis Laboratory, Research Institute for Growth and Development, Department of Pathology, Maastricht University Hospital, PO Box 5800, 6202AZ Maastricht, The Netherlands.
Trends in Molecular Medicine
|December 6, 2005
Summary
Inhibiting angiogenesis, crucial for cancer, is a key treatment strategy. A new method focusing on protein function accelerates the discovery of therapeutic targets for proliferative diseases.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Angiogenesis is a critical process in malignancies and proliferative diseases.
- Traditional gene-expression analysis has limited success in identifying novel therapeutic targets.
- A shift towards functional genomics is emerging for disease-target identification.
Purpose of the Study:
- To highlight a novel approach for identifying therapeutic targets based on protein function.
- To emphasize the acceleration of therapeutic development through functional genomics.
Main Methods:
- Shifting focus from gene expression to protein function for target identification.
- Utilizing high-throughput functional assays related to disease phenotype.
- Implementing functional genomics for disease-target discovery.
Main Results:
- Identification of disease-target genes based on protein function.
- Demonstration of a high-throughput method for target discovery.
- Validation of functional properties directly linked to disease phenotype.
Conclusions:
- Functional genomics offers a more efficient route to identify therapeutic targets.
- This approach significantly reduces the timeline for developing new treatments.
- The protein function-based strategy accelerates clinical translation for proliferative diseases.